Gambaran Umum
Ang LadRx Corporation, na naka-headquarter sa Estados Unidos, ay pangunahing nagpapatakbo sa loob ng industriya ng parmasyutiko, na nakatuon sa pagbuo ng mga nobelang panterapeutika na gamot. Ang isang mahalagang bahagi ng portfolio ng proyekto nito ay kinabibilangan ng pananaliksik at pag-unlad na naglalayong tugunan ang mga kondisyong medikal na may makabuluhang hindi natutugunan na mga klinikal na pangangailangan, tulad ng mga bihirang sakit at kumplikadong mga karamdaman. Gumagamit ang kumpanya ng isang madiskarteng diskarte sa pamamagitan ng paggamit ng makabagong teknolohiya sa pagtuklas at pag-unlad ng gamot upang matiyak ang mga mabisang solusyon sa pangangalagang pangkalusugan. Sa pamamagitan ng mga makabagong proyekto nito, layunin ng LadRx Corporation na pahusayin ang mga resulta ng pasyente sa pamamagitan ng pagpapakilala ng mga epektibong opsyon sa paggamot na nangangako rin ng mas mahusay na pagsunod at mas kaunting mga side effect, na nag-aambag sa reputasyon nito bilang umuusbong na lider sa sektor ng parmasyutiko.
Skor Kualitas, Nilai, dan Momentum
Kartu ini menunjukkan skor Kualitas, Nilai, dan Momentum untuk perusahaan tersebut.
Laporan Laba Rugi: Pendapatan, Laba Operasional, Laba Bersih
- Nilai operating income untuk LadRx Corporation per 2025 Mar 31 adalah -3.51 MM.
- Nilai net income untuk LadRx Corporation per 2025 Mar 31 adalah -2.50 MM.
Period End (TTM) | Revenue (MM) | Operating Income (MM) | Net Income (MM) |
2025-03-31 | -3.51 | -2.50 | |
2024-12-31 | -3.62 | -1.59 | |
2024-09-30 | -3.84 | -2.78 | |
2024-06-30 | -3.85 | -2.77 | |
2024-03-31 | -3.58 | 1.66 | |
2023-12-31 | -3.82 | 0.40 | |
2023-09-30 | -3.89 | 0.31 | |
2023-06-30 | -4.22 | -0.04 | |
2023-03-31 | -4.35 | -3.98 | |
2022-12-31 | -4.56 | -4.20 | |
2022-09-30 | -5.60 | -12.28 | |
2022-06-30 | -5.96 | -12.81 | |
2022-03-31 | -6.00 | -13.19 | |
2021-12-31 | -5.98 | -13.18 | |
2021-09-30 | -5.42 | -5.56 | |
2021-06-30 | -6.68 | -6.64 | |
2021-03-31 | -6.88 | -6.81 | |
2020-12-31 | -6.83 | -6.70 | |
2020-09-30 | -8.45 | -8.28 |
Laporan Laba Rugi: EPS
- earnings per share basic untuk LadRx Corporation pada 2025 Mar 31 adalah -5.04.
- laba per saham yang terdilusi untuk LadRx Corporation pada 2025 Mar 31 adalah -5.04.
Period End (TTM) | Earnings Per Share Basic | Earnings Per Share Diluted |
2025-03-31 | -5.04 | -5.04 |
2024-12-31 | -3.21 | |
2024-09-30 | -5.61 | -5.61 |
2024-06-30 | -5.59 | -5.59 |
2024-03-31 | 3.34 | 3.34 |
2023-12-31 | 0.68 | |
2023-09-30 | 0.36 | 0.36 |
2023-06-30 | -0.53 | -0.53 |
2023-03-31 | -9.41 | -9.41 |
2022-12-31 | -10.57 | |
2022-09-30 | -30.91 | -30.91 |
2022-06-30 | -33.33 | -33.33 |
2022-03-31 | -35.51 | -35.51 |
2021-12-31 | -35.52 | |
2021-09-30 | -15.07 | -15.07 |
2021-06-30 | -18.37 | -18.37 |
2021-03-31 | -19.23 | -19.23 |
2020-12-31 | -19.34 | |
2020-09-30 | -24.44 | -24.44 |
Arus Kas: Operasi, Investasi, Pendanaan
- Nilai cash from operating activities untuk LadRx Corporation per 2025 Mar 31 adalah -1.86 MM.
Period End (TTM) | Cash From Operating Activities (MM) | Cash From Investing Activities (MM) | Cash From Financing Activities (MM) |
2025-03-31 | -1.86 | ||
2024-12-31 | -1.31 | ||
2024-09-30 | -2.88 | 0.00 | |
2024-06-30 | -2.79 | 0.00 | |
2024-03-31 | 1.71 | -0.25 | |
2023-12-31 | 1.01 | -0.32 | |
2023-09-30 | 0.31 | 0.00 | -0.39 |
2023-06-30 | -0.04 | 0.00 | -0.47 |
2023-03-31 | -4.05 | 0.00 | -0.42 |
2022-12-31 | -4.83 | -0.00 | -0.56 |
2022-09-30 | -12.77 | -0.01 | -0.66 |
2022-06-30 | -12.91 | -0.01 | 8.60 |
2022-03-31 | -13.11 | -0.01 | 8.88 |
2021-12-31 | -12.31 | -0.01 | 9.08 |
2021-09-30 | -5.40 | 0.00 | 9.25 |
2021-06-30 | -6.25 | -0.02 | 0.12 |
2021-03-31 | -5.23 | -0.02 | 0.04 |
2020-12-31 | -6.14 | -0.03 | 0.04 |
2020-09-30 | -5.90 | 9.97 | 0.04 |
Metrik Penilaian: PE, PriceToBook, PriceToTBV
- p/e untuk LadRx Corporation pada 2025 Mar 31 adalah -0.88.
- p/libro untuk LadRx Corporation pada 2025 Mar 31 adalah -0.98.
- p/tbv untuk LadRx Corporation pada 2025 Mar 31 adalah -0.98.
- P/Book
- The current closing price divided by the book value per share.
- P/TBV
- The current price divided by the tangible book value per share.
Period End (TTM) | p/e | P/Book | P/TBV |
2025-03-31 | -0.88 | -0.98 | -0.98 |
2024-12-31 | -0.79 | -0.79 | |
2024-09-30 | -0.50 | -1.49 | -1.49 |
2024-06-30 | 0.84 | 4.03 | 4.03 |
2024-03-31 | 2.84 | 10.61 | 10.61 |
2023-12-31 | 2.36 | 0.77 | 0.77 |
2023-09-30 | -21.75 | 0.44 | 0.44 |
2023-06-30 | |||
2023-03-31 | -1.87 | 306.11 | |
2022-12-31 | 7.34 | 7.34 | |
2022-09-30 | -0.62 | 7.34 | 7.34 |
2022-06-30 | |||
2022-03-31 | |||
2021-12-31 | |||
2021-09-30 | |||
2021-06-30 | |||
2021-03-31 | |||
2020-12-31 | |||
2020-09-30 |
Metrik Penilaian: EBitToEv, EBit3YrAvgToEv
- EBIT/EV untuk LadRx Corporation pada 2025 Mar 31 adalah -2.52.
- EBIT (3 tahun) / EV untuk LadRx Corporation pada 2025 Mar 31 adalah -2.06.
Period End (TTM) | EBIT/EV | EBIT (3y)/EV |
2025-03-31 | -2.52 | -2.06 |
2024-12-31 | -2.08 | -1.64 |
2024-09-30 | -4.82 | -8.55 |
2024-06-30 | -2.47 | 7.68 |
2024-03-31 | -0.43 | 6.08 |
2023-12-31 | -0.14 | 2.67 |
2023-09-30 | 0.01 | 2.31 |
2023-06-30 | ||
2023-03-31 | -0.54 | -1.03 |
2022-12-31 | -2.07 | -1.46 |
2022-09-30 | -2.07 | -1.46 |
2022-06-30 | ||
2022-03-31 | ||
2021-12-31 | ||
2021-09-30 | ||
2021-06-30 | ||
2021-03-31 | ||
2020-12-31 | ||
2020-09-30 |
Efektivitas Manajemen
- roa untuk LadRx Corporation pada 2025 Mar 31 adalah -0.72.
- roe untuk LadRx Corporation pada 2025 Mar 31 adalah -4.61.
Period End (TTM) | ROA | ROE | ROIC (Tingkat Pengembalian Investasi Modal) | CROIC | OCROIC |
2025-03-31 | -0.72 | -4.61 | |||
2024-12-31 | -1.20 | -25.88 | |||
2024-09-30 | -0.90 | -2.87 | |||
2024-06-30 | 1.35 | 4.39 | 3.85 | 4.51 | |
2024-03-31 | 0.18 | 15.57 | 2.84 | 4.93 | 7.19 |
2023-12-31 | 0.09 | 0.30 | 0.30 | -0.08 | 0.29 |
2023-09-30 | -0.01 | -0.02 | -0.02 | -0.27 | -0.02 |
2023-06-30 | 0.00 | -0.02 | -0.02 | -0.26 | |
2023-03-31 | -0.64 | -1.28 | |||
2022-12-31 | -0.72 | -0.88 | -9.36 | -10.24 | -9.73 |
2022-09-30 | -0.72 | -0.88 | -9.36 | -10.24 | -9.73 |
2022-06-30 | -1.38 | -1.97 | -4.91 | -1.66 | -4.95 |
2022-03-31 | -1.24 | -1.74 | -3.62 | -1.16 | -3.60 |
2021-12-31 | -1.09 | -1.49 | -2.54 | -0.62 | -2.37 |
2021-09-30 | -0.36 | -0.54 | -0.39 | 0.27 | -0.37 |
2021-06-30 | -0.42 | -0.52 | -0.95 | -0.88 | -0.89 |
2021-03-31 | -0.40 | -0.48 | -0.84 | -0.73 | -0.64 |
2020-12-31 | -0.39 | -0.44 | -0.71 | -0.65 | -0.65 |
2020-09-30 | -0.41 | -0.49 | -0.76 | 0.38 | -0.54 |
Gross Margins
- Margin Kotor
- The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.
- Margin Keuntungan Bersih
- Margin Bersih (juga dikenal sebagai Margin Keuntungan) adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Bersih. Perhitungannya adalah Pendapatan Bersih / Pendapatan.
- Margin Operasi
- Margin Operasi adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Operasi. Perhitungannya adalah Pendapatan Operasi / Pendapatan.
Period End (TTM) | Margin Kotor | Margin Keuntungan Bersih | Margin Operasi |
2025-03-31 | |||
2024-12-31 | |||
2024-09-30 | |||
2024-06-30 | |||
2024-03-31 | |||
2023-12-31 | |||
2023-09-30 | |||
2023-06-30 | |||
2023-03-31 | |||
2022-12-31 | |||
2022-09-30 | |||
2022-06-30 | |||
2022-03-31 | |||
2021-12-31 | |||
2021-09-30 | |||
2021-06-30 | |||
2021-03-31 | |||
2020-12-31 | |||
2020-09-30 |
Pengenal dan Deskriptor
Kunci Indeks Pusat (CIK) | 799698 |
Grupong Pang-industriya
SIC 2836 - Biological Products, Except Diagnostic Substances (Biotech) |